These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7746089)

  • 1. d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin.
    Puig de Parada M; Parada MA; Pothos E; Hoebel BG
    Life Sci; 1995; 56(22):PL415-20. PubMed ID: 7746089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of fenfluramine isomers and metabolites on extracellular 5-HIAA in nucleus accumbens and hippocampus of freely moving rats.
    De Simoni MG; Juraszczyk Z; Fodritto F; De Luigi A; Garattini S
    Eur J Pharmacol; 1988 Aug; 153(2-3):295-9. PubMed ID: 2460361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors.
    Consolo S; Bertorelli R; Russi G; Zambelli M; Ladinsky H
    J Neurochem; 1994 Jun; 62(6):2254-61. PubMed ID: 8189232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
    Rothman RB; Clark RD; Partilla JS; Baumann MH
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
    Callaway CW; Wing LL; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain.
    Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R
    Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
    Borroni E; Ceci A; Garattini S; Mennini T
    J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramine-induced elevations of extracellular 5-HT concentrations.
    Feng N; Telefont M; Kelly KJ; Orchinik M; Forster GL; Renner KJ; Lowry CA
    Horm Behav; 2009 Jun; 56(1):149-57. PubMed ID: 19371745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats.
    Datla KP; Curzon G
    Eur J Pharmacol; 1997 Aug; 333(1):27-31. PubMed ID: 9311657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
    Baumann MH; Ayestas MA; Dersch CM; Brockington A; Rice KC; Rothman RB
    Synapse; 2000 May; 36(2):102-13. PubMed ID: 10767057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
    Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
    Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis.
    Rocher C; Gardier AM
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):422-8. PubMed ID: 11330336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.